BRIEF-Metavia Inc - Announces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel
Reuters
Feb 04
BRIEF-Metavia Inc - Announces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel
Feb 4 (Reuters) - SyntekaBio Inc 226330.KQ:
METAVIA INC - ANNOUNCES POSITIVE AI-MODELING RESULTS FROM ONGOING SYNTEKABIO COLLABORATION, CONFIRMING KEY THERAPEUTIC TARGETS FOR VANOGLIPEL
Source text: ID:nPn8G9Qy9a
Further company coverage: 226330.KQ
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.